ANI Pharmaceuticals (ANIP)

[Just the facts maam]

According to Samy's Executive Employment Agreement filed November 26, 2021, Samy's Outside Business interest and Engagements show that he has stake is the full integration of getting Novitium products ti market :

Nuray Chemicals Pvt. Ltd (42.5%) - API manufacturing facility located in Chennai, Tamil Nadu, India .
o Develops and manufactures various API’s for developed and rest of the world (ROW) markets

SThree Chemical Pvt. Ltd (98%) – Intermediate, API manufacturing facility located in Chennai, Tamil Nadu, India
o Develops and manufactures various intermediates for NuRay and API’s for developed and ROW markets

SaiMirra Innopharm Pvt. Ltd (33%) - Finished dose contract manufacturer that supplies ROW markets and PICS countries with prescription drugs, located in Chennai, Tamil Nadu, India

Delvin Formulations (33%) – Distributes various prescription products in India, located in Chennai, Tamil Nadu, India

Scitus Pharma Services Pvt. Ltd (40%) - Clinical research organization that conducts BA/BE studies for Novitium Pharma and other generic pharmaceutical companies. The facility is located in Chennai, Tamil Nadu, India

Samy Hotel (100%) - Hotel located in Tamil Nadu, India

Filing

Even Esjay Pharma LLC, the company owning the shares has been selling has the same address and phone number as Novitium, 70 Lake Drive, East Windsor NJ and [phone].

Hard to believe that Novitium doesn't have first right of refusal for any of Nuray Chemicals products and IP. Which bodes well for its future pipeline.